Literature DB >> 16309189

Kinetic studies of the radical-scavenging activity of ebselen, a seleno-organic compound.

Seiichiro Fujisawa1, Yoshinori Kadoma.   

Abstract

Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is now under active investigation as a neuroprotective and anticancer agent. In the present study, the induction period method was used to investigate the antioxidant activity of ebselen in the radical polymerization of methyl methacrylate (MMA) at 70 degrees C. The reaction of ebselen with growing MMA radicals (lipid radicals) showed a k(inh) of 4 x 10(4) M(-1)s(-1). This value was similar to that for mercaptomethylimidazole (MMI, a thiol) and 10-fold greater than that for butylated hydroxyanisole (BHA). The ratio of the rate of chain inhibition to that of chain propagation (CI/CP) for ebselen, MMI and BHA was 0.1, 0.01 and 0.001, respectively, whereas the stoichiometric factor (n, the number of free radicals trapped by one mole of antioxidant moiety) for the corresponding compounds was 0.02, 0.2 and 2, respectively. Ebselen preferentially affected CP rather than CI, indicating that it was an effective scavenger (suppressor) of growing MMA radicals. These results suggest that ebselen is a potent suppressor of polyunsaturated fatty acid (PUFA) radicals, which are harmful radicals in biological systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309189

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors.

Authors:  Ajit G Thomas; Camilo Rojas; Cordelle Tanega; Min Shen; Anton Simeonov; Matthew B Boxer; Douglas S Auld; Dana V Ferraris; Takashi Tsukamoto; Barbara S Slusher
Journal:  Biochem Biophys Res Commun       Date:  2013-07-10       Impact factor: 3.575

2.  Ebselen alters mitochondrial physiology and reduces viability of rat hippocampal astrocytes.

Authors:  Patricia Santofimia-Castaño; Ginés M Salido; Antonio González
Journal:  DNA Cell Biol       Date:  2013-03-15       Impact factor: 3.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.